Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats

Biomed Pharmacother. 2019 Sep:117:109124. doi: 10.1016/j.biopha.2019.109124. Epub 2019 Jun 19.

Abstract

Aim: Cardiovascular diseases, such as coronary heart disease and myocardial infarction (MI) are currently considered as the leading causes of death and disability. The aim of the present study is to investigate the effects of Xin-Ji-Er-Kang (XJEK) on kidney injury and renal oxidative stress. In addition, the associated mechanism involved in these processes was examined in an MI model, and particularly focused on the nuclear factor erythroid 2-related factor (NRF2)/heme oxygenase-1 (HO-1) pathway.

Materials and methods: A total of 138 Sprague-Dawley rats were used in the present study. The control group was designated as 0 wk (n = 8). A total of 3 phases (2, 4, 6 wk) of administration were used in the sham-operated groups (sham, n = 10), MI groups (MI, n = 10), MI + XJEK groups (XJEK, n = 10) and MI + fosinopril groups (fosinopril, n = 10). Additional 10 rats were used to evaluate the infarct area. At 2, 4 or 6 wk post-MI, the hemodynamic parameters were monitored, the rats were sacrificed, then blood, heart and renal tissues were collected for furtherly analysis.

Results: The results indicated that XJEK administration continuously ameliorated renal hypertrophy index, blood urea nitrogen and cystatin C concentrations. XJEK further improved post-MI cardiac function by limiting scar formation and caused a downregulation in the hemodynamic parameters at the end of 2 and 4 wk. The hemodynamic parameters were upregulated after 6 wk treatment with XJEKcompared with those noted in the MI groups. Similarly, XJEK treatment for 2 wk potentiated Nrf2 nuclear translocation and HO-1 expression and inhibited the deficiency of nuclear Nrf2 and HO-1 at 6 wk post-MI compared with that of the MI groups, indicating the attenuation of the renal oxidative stress condition. The levels of malondialdehyde and angiotensin II (Ang II) in plasma and renal tissues, as well as the levels of aldosterone, 8-hydroxydeoxyguanosine, angiotensin II type 1 receptor and NADPH Oxidase-4 in the kidney tissue significantly decreased following XJEK treatment for 6 wk. In addition, the XJEK treatment groups revealed a significant upregulation in the activity of superoxide dismutase and in the total antioxidant capacity activity compared with those noted in the corresponding MI groups.

Conclusion: These results demonstrated that progressive nephropathy in MI rats was associated with intrarenal activation of the renin-angiotensin-aldosterone system. Concomitantly, this process was associated with oxidative stress and impaired Nrf2 activation. The improvement in the severity of nephropathy by XJEK in this model may be associated with the reversal of these abnormalities.

Keywords: Acute and chronic kidney injury; Myocardial infarction; Nrf2; Oxidative stress; Renin-angiotensin-aldosterone system; Xin-Ji-Er-Kang.

MeSH terms

  • Angiotensin II / metabolism
  • Animals
  • Blood Urea Nitrogen
  • Cystatin C / metabolism
  • DNA Damage
  • Down-Regulation / drug effects
  • Drugs, Chinese Herbal / pharmacology*
  • Heme Oxygenase-1 / metabolism*
  • Hemodynamics / drug effects
  • Kidney / drug effects
  • Kidney / injuries*
  • Kidney / pathology*
  • Kidney / physiopathology
  • Myocardial Infarction / blood
  • Myocardial Infarction / complications*
  • Myocardial Infarction / physiopathology
  • NADPH Oxidase 4 / metabolism
  • NF-E2-Related Factor 2 / metabolism*
  • Organ Size / drug effects
  • Oxidative Stress / drug effects*
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1 / metabolism
  • Signal Transduction* / drug effects

Substances

  • Cystatin C
  • Drugs, Chinese Herbal
  • NF-E2-Related Factor 2
  • Receptor, Angiotensin, Type 1
  • xin-ji-er-kang
  • Angiotensin II
  • Heme Oxygenase-1
  • NADPH Oxidase 4
  • Nox4 protein, rat